Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 5/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.53 |
| ▸ | WNT3A | P56704 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL745193 | 0.87 | PKM (0.54) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30627606 | 0.87 | PKM (0.54) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6482119 | 0.84 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1MAPTNPC1 | |
| SCHEMBL16230592 | 0.83 | KMT2A (0.43) | ALDH1A1MAPK1KMT2AMEN1MAPT | |
| SCHEMBL31371765 | 0.83 | RAB9A (0.48) | MAPTNPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL6165864 | 0.82 | ALDH1A1 (0.78) | ALDH1A1MAPK1KMT2AMEN1NPC1 | |
| SCHEMBL16773395 | 0.82 | MAPT (0.53) | KMT2AMEN1MAPTNPC1RAB9A | |
| SCHEMBL107850 | 0.82 | MAPT (0.53) | KMT2AMEN1MAPTNPC1RAB9A | |
| SCHEMBL14959930 | 0.82 | MAPT (0.53) | KMT2AMEN1MAPTNPC1RAB9A | |
| SCHEMBL15982627 | 0.82 | MAPT (0.53) | KMT2AMEN1MAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170044418-A1 | HIGH TEMPERATURE STABILIZER FOR POLYMER-BASED TREATMENT FLUIDS | SCHLUMBERGER TECHNOLOGY CORP (US) | 2017-02-16 | — | — | US | claimed |
| WO-2016160363-A1 | METHOD FOR TREATING A SUBTERRANEAN FORMATION | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2016-10-06 | — | — | WO | claimed |
| US-20160289544-A1 | METHOD FOR TREATING A SUBTERRANEAN FORMATION | SCHLUMBERGER TECHNOLOGY CORPORATION | 2016-10-06 | — | — | US | claimed |
| WO-2015171857-A1 | HIGH TEMPERATURE STABILIZER FOR POLYMER-BASED TREATMENT FLUIDS | SCHLUMBERGER CANADA LIMITED (CA) | 2015-11-12 | — | — | WO | claimed |
| CN-101258119-B | Process for preparing 3, 4-dioxo-substituted aromatic aldehydes | ENDURA SPA | 2014-06-18 | — | — | CN | claimed |
| CN-101258119-A | Process for preparing 3, 4-dioxo-substituted aromatic aldehydes | ENDURA SPA (IT) | 2008-09-03 | — | — | CN | claimed |
| EP-4680226-A2 | ACYLSULFONAMIDE KAT6A INHIBITORS | Olema Pharmaceuticals, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20260015327-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | OLEMA PHARMACEUTICALS INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12428379-B2 | Acylsulfonamide KAT6A inhibitors | OLEMA PHARMACEUTICALS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250250294-A1 | COMPOUND, METAL COMPLEX, OLEFIN POLYMERIZATION CATALYST COMPOSITION, OLEFIN POLYMERIZATION CATALYST, AND METHOD FOR PRODUCING OLEFIN-BASED POLYMER | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| EP-4596562-A1 | COMPOUND, METAL COMPLEX, CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION AND METHOD FOR PRODUCING OLEFIN POLYMER | Mitsubishi Chemical Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| CN-119998304-A | Compound, metal complex, catalyst composition for olefin polymerization, catalyst for olefin polymerization, and process for producing olefin polymer | 三菱化学株式会社 | 2025-05-13 | — | — | CN | disclosed |
| EP-0778833-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-06-18 | — | — | EP | disclosed |
| WO-1997004781-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-02-13 | — | — | WO | disclosed |
| WO-1996030358-A1 | PHENYL DERIVATIVES USEFUL AS ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1996-10-03 | — | — | WO | disclosed |
| WO-1996007653-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-14 | — | — | WO | disclosed |
| US-4865617-A | Dyeing compositions for keratinous fibres, especially for human hair, containing oxidation dye precursors and heterocyclic couplers | L'OREAL (FR) | 1989-09-12 | — | — | US | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3962415-A | Insecticide evaporator comprising DDVP with synergized benzodioxole compound as stabilizer | AIRWICK INDUSTRIES, INC. (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428379-B2 | Acylsulfonamide KAT6A inhibitors | KAT6A, KAT2A, KAT6B | ALDH1A1 2242/4885MAPK1 2706/4885KMT2A 67/4885 |
| US-20250250294-A1 | COMPOUND, METAL COMPLEX, OLEFIN POLYMERIZATION CATALYST COMPOSITION, OLEFIN POLYMERIZATION CATALYST, AND METHOD FOR PRODUCING OLEFIN-BASED POLYMER | OSTC, PORCN, POF1B | ALDH1A1 2226/4885MAPK1 1564/4885KMT2A 1852/4885 |
| US-20260015327-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | KAT6A, KAT2A, KAT6B | ALDH1A1 1068/4885MAPK1 1838/4885KMT2A 104/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | ALDH1A1 4757/4885MAPK1 3024/4885KMT2A 3227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.